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Abstract
We used morphological, immunohistochemical and functional assessments to determine the impact of genetically-modified
peripheral nerve (PN) grafts on axonal regeneration after injury. Grafts were assembled from acellular nerve sheaths
repopulated ex vivo with Schwann cells (SCs) modified to express brain-derived neurotrophic factor (BDNF), a secretable
form of ciliary neurotrophic factor (CNTF), or neurotrophin-3 (NT3). Grafts were used to repair unilateral 1 cm defects in rat
peroneal nerves and 10 weeks later outcomes were compared to normal nerves and various controls: autografts, acellular
grafts and grafts with unmodified SCs. The number of regenerated bIII-Tubulin positive axons was similar in all grafts with
the exception of CNTF, which contained the fewest immunostained axons. There were significantly lower fiber counts in
acellular, untransduced SC and NT3 groups using a PanNF antibody, suggesting a paucity of large caliber axons. In addition,
NT3 grafts contained the greatest number of sensory fibres, identified with either IB4 or CGRP markers. Examination of semi-
and ultra-thin sections revealed heterogeneous graft morphologies, particularly in BDNF and NT3 grafts in which the
fascicular organization was pronounced. Unmyelinated axons were loosely organized in numerous Remak bundles in NT3
grafts, while the BDNF graft group displayed the lowest ratio of umyelinated to myelinated axons. Gait analysis revealed
that stance width was increased in rats with CNTF and NT3 grafts, and step length involving the injured left hindlimb was
significantly greater in NT3 grafted rats, suggesting enhanced sensory sensitivity in these animals. In summary, the selective
expression of BDNF, CNTF or NT3 by genetically modified SCs had differential effects on PN graft morphology, the number
and type of regenerating axons, myelination, and locomotor function.
Citation: Godinho MJ, Teh L, Pollett MA, Goodman D, Hodgetts SI, et al. (2013) Immunohistochemical, Ultrastructural and Functional Analysis of Axonal
Regeneration through Peripheral Nerve Grafts Containing Schwann Cells Expressing BDNF, CNTF or NT3. PLoS ONE 8(8): e69987. doi:10.1371/
journal.pone.0069987
Editor: Hemachandra Reddy, Oregon Health & Science University, United States of America
Received February 28, 2013; Accepted June 14, 2013; Published August 9, 2013
Copyright:  2013 Godinho et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work and MJG were partially supported in the early stages by funds from the Princess Margaret Hospital for Children, Subiaco, Australia. MJG was
supported by an Australian Postgraduate Award from The University of Western Australia and by a Mary and Elsie Stevens Bursary from the Australian Federation
of University Women (Western Australia). Aspects of this work were supported by grants from the NHMRC and WA Neurotrauma Research Program. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: alan.harvey@uwa.edu.au
¤a Current address: Faculty-Preventive and Social Medicine NZPhvC Health Sciences, Dunedin School of Medicine, Otago, New Zealand
¤b Current address: Stanford Partnership for Spinal Cord Injury and Repair, Stanford Institute for Neuro-Innovation and Translational Neurosciences, and
Department of Neurosurgery, Stanford, California, United States of America
Introduction
Peripheral nerve (PN) injuries are often microsurgically repaired
by coaptation of transected nerve stumps. However if the nerve
defect is too large, due to nerve stump retraction or following
pruning to remove necrotic tissue, a bridging graft is needed to
restore continuity. Autologous nerve grafts are the preferred
option, commonly harvested from sensory sural nerves [1,2], yet
functional recovery can be suboptimal, perhaps due to neuronal
loss, deterioration of distal nerve stump, or failure to recruit
Schwann cells (SCs) of the appropriate phenotype [3–6].
Moreover, harvesting autografts may result in functional impair-
ment and neuroma formation at the donor site. Use of allograft or
xenograft material requires immunosuppression, and graft rejec-
tion results in axonal loss [7–9]. Alternative substrates include
muscles, tendons and veins, although none have yet matched the
performance of autografts [10,11]. Bridges using synthetic
materials have the advantage of ease of fabrication and
availability, although they may not be optimal for repairing large
nerve defects and may induce inflammatory reactions [12].
An approach that may potentiate regeneration and minimize
adverse effects is to develop chimeric grafts composed of optimized
support structures, cell types and molecules [2,13,14]. For
example, because cells in PN tissues are the primary immunogenic
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component [9,15,16], and the essential PN structure and
organization is maintained after freeze-thawing, it is possible to
repopulate allogeneic acellular PN sheaths ex vivo with cultured,
congeneic SCs that support axonal regeneration in vivo [17,18].
Furthermore, after PN injury, neuronal survival and axonal
regrowth is enhanced by administration of neurotrophic factors
delivered systemically [10] or locally using osmotic pumps [19–
21]. Neurotrophic factors have also been delivered by direct
injection into the PN of viral vectors encoding these factors [22–
24] or in vivo injection of genetically modified SCs [25]. The
former technique results in transduction of diverse cell types,
including not only SCs but also fibroblasts and endothelial cells
[26,27].
Here we used an alternative method for local neurotrophic
delivery, shown previously to promote successfully the regrowth of
injured axons in the adult rat visual system [28,29]. Our aim was
to compare the effects of different neurotrophic factors on various
aspects of regeneration through PN bridging grafts. Purified adult
SCs were transduced ex vivo using lentiviral (LV) vectors to express
either brain-derived neurotrophic factor (BDNF), a secretable
form of ciliary neurotrophic factor (CNTF), or neurotrophin-3
(NT3). Genetically modified SCs were then injected into cell-free
PN sheaths and 24 hr later the reconstituted grafts inserted into a
unilateral 1 cm gap in adult rat peroneal nerves. This gap size
allows for direct comparison of the effects of each neurotrophic
factor on axonal regeneration and myelination, while minimising
the impact related to the length of the nerve defect itself [1]. For
comparison, uninjured peroneal nerves, autografts, acellular grafts,
and grafts containing unmodified SCs cultures were also
examined. In behavioral studies we compared walking patterns
prior to, and 1 and 8 weeks after surgery using the RatwalkH gait
analysis system, a software written and developed independently
but which analyzes parameters similar to those previously
described in the Catwalk system [30]. Graft morphologies were
compared 10 weeks post-transplantation, and the number and
type of regenerating axons were analyzed using immunohisto-
chemistry. The number, distribution and extent of myelination of




Sciatic nerves from young adult male Fischer 344 rats were used
as the source for SCs, which were isolated and purified using
established protocols [31,32]. For each culture, 5 animals were
overdosed (sodium pentobarbitone, Lethabarb), their sciatic nerves
collected and placed in Liebovitz’s L-15 medium (Invitrogen).
Sciatic nerves were chosen for their high SC yield and because
they are a mixed nerve. This is important because there is
evidence that SCs ‘‘express distinct sensory and motor phenotypes
that are associated with the support of regeneration in a
phenotype-specific manner’’ [4]. Nerves were stripped of epineu-
rium, sectioned into 1–2 mm pieces and incubated at 37uC with
5% CO2 in culture dishes with D-10 media (Dulbecco’s Modified
Eagle’s Medium (DMEM) (Sigma) containing 10% foetal bovine
serum (FBS) (Sigma), 1% L-glutamine (Invitrogen) and 1%
penicillin/streptomycin (Invitrogen). Fibroblasts migrated out of
the PN explants, the latter transferred weekly and plated cells
discarded. After 3–4 weeks, explants were dissociated overnight
with 1.25 U/mL dispase (Boehringer Mannheim Biochemicals)
and 0.05% collagenase (Sigma) in DMEM with 15% FBS. SCs
cultures were expanded on poly-L-lysine (Sigma) coated dishes in
D-10 media containing 20 mg/mL bovine pituitary extract
(GibcoBRL) and 2 mM forskolin (Sigma).
Lentiviral vectors and SCs transduction
Genetic modification of SCs using LV was approved by the
Office of Gene Technology Regulator, Australia. The LV
constructs used for expression of neurotrophic factors were
previously characterized, and expression and release of neuro-
trophic factors in SCs and peripheral tissues confirmed, both in
vitro and in vivo [22,23,26,28,29]. In brief, cDNA encoding either a
rat CNTF fragment (which contained the signal sequence required
for the release of human growth hormone), BDNF or NT3, were
cloned into the LV transfer vector backbone pRRLsin-
PPThCMV-MCS-wpre and LV stocks produced by co-transfec-
tion of the vector, packaging and envelope plasmids into 293T
cells. Titers were between 108 and 109 transducing units/ml.
About 106 SCs were plated for 24 hr prior to transduction with
LV-BDNF, LV-CNTF or LV-NT3 at a multiplicity of infection of
50. After 24 hr, the D10 medium was refreshed and cells
incubated for 48 hr to allow for maximum transgene expression.
In a preliminary sciatic nerve graft experiment, LV encoding
green fluorescent protein (GFP) was used to verify SC viability and
sustained transgene expression after injection of transduced cells
into grafts and transplantation into a PN injury site.
Acellular nerve sheaths
To create acellular nerve sheaths, cells were eliminated by 5
consecutive cycles of 5 min immersion in liquid nitrogen and
5 min thawing at room temperature and storage at 280uC. The
freeze-thaw cycles killed the cells but maintained basal lamina
integrity, providing flexible nerve sheaths that can be effectively
repopulated with cultured cells [17,18]. Acellular sheaths were
prepared from either sciatic or peroneal nerves of adult male
Wistar rats and inserted into the corresponding nerve in Fischer
344 host rats.
Cellular reconstitution of genetically modified nerve
sheaths
Three days after transduction, cultured SCs were rinsed twice
with Ca2+ and Mg2+ free Hanks balanced salt solution (Sigma) and
detached from plates by incubation for 5 min at 37uC with 0.02%
EDTA (Invitrogen) and 0.05% trypsin (CSL), then inactivated
with D10. Cells were collected by centrifugation at 1000 rpm and
resuspended in D10 to a final concentration of 56104/ml [18].
Acellular nerve sheaths were placed in D10, trimmed to 1 cm
length and 1 ml of the SC suspension slowly injected via a glass
micropipette using a Hamilton syringe into both ends of each
nerve sheath, giving an approximate concentration of 105 SCs/
sheath. This number of cells has previously been shown to result in
complete colonization of the nerve sheaths [18,28,29]. To allow
further SC infiltration, a small amount of cell suspension was
placed around each nerve and further incubated for 24 hr.
Ethics Statement
Surgical procedures followed NHMRC guidelines and the study
was approved by the University of Western Australia Animal
Ethics Committee (approval RA3/100/471). Rats were obtained
from the Animal Resource Centre, WA, and housed under
standard conditions with a 12 hr light/dark cycle and ad libidum
access to food and water. All surgical procedures were performed
under anaesthesia and animals received antibiotic treatment
(Benacillin, 200 ml/100 g) to reduce the risk of infections and an
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analgesic (Temgesic, 20 mg/kg) to minimize post-operative
discomfort.
Host animals
Adult (8–10 weeks old) male Fischer 344 rats received a
unilateral 1 cm peripheral nerve cut, either on the sciatic nerve in
the preliminary study, in which we assessed SC survival and the
continued expression of transgenes at 8 weeks following trans-
plantation, or on the peroneal nerve in the main study. The 1 cm
gap was then repaired using different types of chimeric nerve
grafts. Experimental groups received acellular nerve sheaths
repopulated with SCs genetically modified with LV to over
express BDNF, CNTF or NT3, while control groups received
acellular nerve sheaths with unmodified SCs, acellular nerve
sheaths without any cells, or autografts. The normal control group
included uninjured rats that were processed to obtain intact
peroneal nerve material. In a preliminary experiment, 3 rats
received acellular sciatic nerve sheaths repopulated with SCs
transduced with LV-GFP to verify long-term transduction. Given
that SCs rapidly migrate in and out of PN to grafts [33], labelling
of transplanted SCs with GFP made it possible to distinguish
donor from host SCs, allowing an assessment of their viability and
distribution after surgery.
Surgical injury model and tissue collection
Each host rat was anesthetized with an intra-peritoneal injection
(1 mL/kg body weight) of a mixture of equal volume of ketamine
(100 mg/mL) and xylazine (20 mg/mL). Either the sciatic
(preliminary study – to confirm SC viability and long-term
transgene expression after transplantation) or the peroneal nerve
(main study – to investigate the effects of overexpressing different
neurotrophic factors on axonal regeneration), in the left hind limb
was exposed and a 1 cm segment was removed. The nerve gap
was repaired with different types of grafts, all attached to host
nerve stumps using 10/0 nylon suture (Ethicon), and the injury
closed with 6/0 suture (Ethicon). Animals received Benacillin
(200 ml/100 g of body weight) intra-muscularly and Temgesic
(20 mg/kg body weight) subcutaneously as post-operative care.
Ten weeks after surgery (8 weeks in preliminary study) grafted
rats received a lethal dose of sodium pentobarbitone (Lethabarb,
325 mg/ml, intra-peritoneal). Fresh grafted nerves were collected,
gently straightened, attached to a wooden spatula and fixed in 4%
paraformaldehyde for 3 hr at 4uC, after which a 1 mm block was
taken from the distal end of 3 grafts from each group. These
samples were placed in 2% glutaraldehyde and processed for
electron microscopy, while remaining tissue was cryoprotected in
30% sucrose solution for 24 hr at 4uC. To analyze distinct nerve
regions, samples were divided into 5 blocks (Fig. 1A). Each block
was embedded in tissue freezing medium (Leica), snap frozen in
isopentane (2-methylbutane) and stored at 280uC. Frozen blocks
from the host proximal (Block A) and distal (Block E) nerve stumps
were sectioned at 16 mm thickness using a Leica CM3050 cryostat
into series of 7 slides, each with 8 cross-sections. A series of 12
slides was prepared by cutting grafts (Block C) into 10 mm thick
longitudinal sections, resulting in 7–12 sections per slide,
depending on the graft. Sections were collected onto gelatine
coated slides, air-dried and stored at 220uC.
Immunohistochemical staining of cryosections of nerves
Slides were placed in a humidified dark chamber at room
temperature with gentle agitation. Sections were rinsed with PBS
(365 min), blocked for 1 hr in PBS with 10% normal horse serum
and 0.2% Triton X-100, and incubated overnight in primary
antibodies. This incubation was done at 4uC for antibodies to
axonal neurofilaments (PanNF) (Invitrogen #18-0171Z, 1:500),
neuronal class III b-Tubulin (Covance#MMS-435P, 1:400), S100
(DAKO #Z0311, 1:500), myelin basic protein (MBP) (Abcam
#120.24040, 1:100), macrophages (ED1, Millipore MAB1435,
1:500), or laminin (Sigma #L9393, 1:400). Immunostaining was
done at room temperature for antibodies to calcitonin gene-related
peptide (CGRP) (AbDSerotec #1720-9007, 1:1000) to label axons
of primary peptidergic sensory neurons. Non-peptidergic sensory
axons were identified by histochemical reaction with fluorescently
labelled isolectin B4 (IB4) (Vector Laboratories, 1:100) [34]. Each
immunostaining run included a negative control without primary
antibody. After 365 min washes with PBS, appropriate secondary
antibody dilutions were added: goat anti-mouse Cy3 (Jackson
Immuno/research Labs #115-166-006, 1:500); goat anti-rabbit
Cy3 (Jackson Immuno/research Labs #111-166-006, 1:300);
donkey anti-goat Cy3 (Jackson Immuno/research Labs #705-
166-147, 1:1000); goat anti-rabbit FITC (Sigma F6005, 1:100);
and rabbit anti-goat FITC (sigma F7367, 1:100). Sections were
washed with PBS, mounted with citifluor or fluorescence
mounting medium (DAKO), and cover-slipped. Stained sections
were kept at 4uC.
Quantification of axonal numbers
Counts of bIII-Tubulin+ axons were made from cross-sections
of proximal and distal host nerve stumps. Sections were
photographed using a 106 objective and a QuantiFIRE camera
operated by PictureFrameTM software (Optronics). The outline of
each section was manually traced using Image-Pro Plus software
(MediaCybernetics) and axonal number quantified using a filter
algorithm plugged to the software [23]. The number of
regenerating axons was also quantified in longitudinal graft
sections immunohistochemically stained for bIII-Tubulin or
PanNF. In sections stained with bIII-Tubulin, 3 photographs
were taken and on each of them a line was placed to mark 1.2, 2.4
and 3.6 mm from the proximal end of the section. The number of
axons crossing these lines was counted and the section width was
measured. Sections stained with PanNF, IB4 and CGRP were
photographed only at the middle location of bIII-Tubulin analysis
(i.e. 2.4 mm from the proximal edge of the section), and axon
numbers and section width measured and quantified (Image-Pro
Express software, MediaCybernetics). Given that IB4 labels not
only small, nonpeptidergic, unmyelinated, sensory nociceptive
neurons and their axons [34] but also endothelial cells [35–37], the
marker PanNF was used to check that IB4 labelling was associated
with clearly defined axonal profiles.
Statistical analysis of axonal counts
Statistical analyses were carried out using PASW software
following Pallant guidelines [38]. Descriptive statistics were done
and mean values (M) and standard error of the mean (SEM) were
plotted. The size of each sample (n) is indicated, and corresponds
to the number of animals within each group. Parametric tests were
used preferentially and logarithmic or square root transformations
were applied to data in order to correct for non-normality.
Parametric tests included linear mixed models, with a fixed effect
of experimental group and block and a random effect of animal
within group and also including analysis of interactions between
variables [39], using a Sidak adjustment to account for multiple
comparisons, and one-way analysis of variance, followed by least
significant difference (LSD) test when significant differences were
found between groups. Non-parametric Kruskal-Wallis tests
followed by Dunn’s post-hoc analysis were performed with all
pairwise comparisons when significant differences were found
between groups, and median (Md) values calculated. For all tests,
Neurotrophic Factors and Peripheral Nerve Repair
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significance levels were set at p,0.05, although Bonferroni
corrections were applied whenever multiple tests were carried
out on the same data. Note that the specific statistical analyses
selected for each parameter are presented in legends to relevant
Figures and Tables, and are explained in detail in Statistical
Information S1.
Quantification of axons in semi-thin sections
From the distal end of Block C of 3 grafts in each group a 1 mm
block was collected and fixed in 2% glutaraldehyde. Further
processing, including bright field photography of semi-thin plastic
sections, was done by an independent technician and all
subsequent counts were done blind. Using Image-Pro Express
5.1 software, images were digitally zoomed and myelinated profiles
were counted within 4 areas of 4004 mm2 in each section. The
number of myelinated axons/mm2 was calculated and assessed
using one-way analysis of variance. The number of samples and
the power of each statistical test are indicated in the results. In
addition, in a semi-thin section from three nerves in each of the
SCs, BDNF, CNTF and NT3 graft groups, the diameter of
fascicles was measured and compared using ANOVA and
Bonferroni post-hoc test.
Analysis and quantification in ultrathin sections
Electron micrographs were collected in 5 different locations on
each ultra-thin section. Locations were selected in a systematic but
random manner and files identified by a code so that the origin of
each sample was not known. From each location, one set of
micrographs was used to quantify all myelinated and unmyelin-
ated axons within an area of 325 mm2, as well as the number of
unmyelinated axons in Remak bundles. Only those axons that
were entirely within the image were quantified. Ratios between
unmyelinated and myelinated axons were calculated. Another set
of micrographs was used to measure the area and diameter of
axons and fibers, the latter including the myelin sheath. The
difference between the total area of each fiber and the area of the
axon provided the myelin area. The diameter of each myelinated
axon was divided by the diameter of the entire fiber to calculate
the G-ratio. All data were first analyzed to determine M, SEM,
variance and range of distribution with minimum and maximum
values, and percentile distributions including Md. Data were then
compared using Kruskal-Wallis tests followed by a Dunn’s post-
hoc tests with all pairwise comparisons (significance level, p,0.05).
Frequency plots were used to display all data, except G-ratios,
which were plotted against axonal diameter.
Figure 1. Tissue sampling protocol and RatwalkH schematic. (A) Each grafted nerve was divided into blocks: proximal host nerve stump (Block
A), proximal suture (Block B), graft itself (Block C), distal suture (Block D), and distal host nerve stump (Block E). Either cross sections (circles) from
Blocks A and E or longitudinal sections (rectangles) from Block C were collected for immunohistochemistry. Additionally, a block was taken from the
distal end of 3 grafts from each group to collect semi- and ultra-thin cross-sections for electron microscopy (EM). (B, C) Functional recovery was
assessed using the RatwalkH [side view of the setup (B)], consisting of a glass walking platform [front view (C)] attached to a box containing a
fluorescence bulb from which the light escapes only through a narrow slit into the glass. Light is scattered from the glass at each point of contact
with the animals’ paws. Walks were recorded and analyzed using the RatwalkH software (images B and C modified from 30).
doi:10.1371/journal.pone.0069987.g001
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Analysis of locomotor function
Functional recovery was assessed using the RatwalkH method-
ology, a computerized gait analysis system similar in principle to
other systems [30,40], that quantifies several locomotor parame-
ters (Fig. 1 B, C). Initially animals were allowed to familiarize with
the setup during 3 training sessions, after which videos of animals
walking along a glass platform were recorded 2 days before
surgery, to establish baseline values, and then 1 and 8 weeks after
surgery. Analysis of the recordings was done blinded to the group
to which the animal belonged. Each recording was loaded into the
RatwalkH software, cropped to eliminate redundant frames,
usually at the beginning and end of the recording where no paws
could be seen, and in each frame of the cropped video all paw
prints were manually identified and labelled. Data was saved as a
composite file and the software quantified several gait parameters.
Details on the statistical analyses are explained in Statistical
Information S1.
Given that the RatwalkH was originally developed to evaluate
gait recovery following spinal cord injuries we used it in a
preliminary study (data not shown) to assess which of the output
parameters were more suitable for the evaluation of locomotor
function after PN injuries. Two parameters are presented here: (i)
stance width, which considers the mean distance between the right
and left forelimb (rf-lf) and between the right and left hindlimb (rh-
lh); (ii) step length, which is the measurement between ipsilateral
limbs, that is, the mean distance between placements of the rf in
relation to the rh and the mean distance between placements of
the lf in relation to the lh. Analysis included recordings from 4
animals from groups with neurotrophic factor-delivering grafts
(BDNF, CNTF and NT3) and the SC group as control. Distances
between limbs in all graphs are expressed in pixels. Data were
averaged for each group and analyzed using a multivariate
analysis of variance, including Box’s M Test of Equality of
Covariance Matrices (using p= 0.001) and Levene’s Test of
Equality of Error Variances (using p= 0.05) to check that
experimental data satisfied required assumptions for the analysis,
with LSD post-hoc tests performed to specifically identify
significant differences.
Results
Transgene expression and survival of transplanted SCs
Using an LV-GFP construct we first showed sustained transgene
expression in many SCs for up to 8 weeks after transplantation of
reconstituted PN grafts into injured sciatic nerve (Fig. 2A). Double-
labelling of sections with S100 confirmed the identity of grafted
GFP cells (white arrows in Fig. 2B–D). GFP negative SCs were
also seen, many presumably host SCs that had migrated into the
grafts [33]. Thus as described previously [18,28], LV-modified SC
remained viable in the grafts for many weeks and can be used as
vehicles to provide sustained delivery of transgene-derived factors
within transplanted chimeric PN [28,29].
Axonal quantification in cross-sections of proximal and
distal host nerve stumps
In the main study, primary SC cultures were transduced with
LV-BDNF, LV-CNTF or LV-NT3 and seeded into acellular
nerve sheaths to bridge a 1 cm peroneal nerve defect. This size
gap permits an analysis of the relative impact of each neurotrophic
factor on axonal regeneration and myelination, and reduces any
confounding effect related to the length of the nerve defect itself
[1]. Grafted nerves were collected after 10 weeks, and along with
normal nerves and other control groups, divided into 5 blocks for
immunohistochemical analysis (Fig. 1A). Axons were highly
disorganized close to host-graft suture areas (Blocks B and D)
and impossible to count, hence we focused on the central portion
of each graft (Block C), and the proximal (Block A) and distal
(Block E) host nerve stumps, because they reflect the number of
neurons surviving injury and the number of axons potentially
reinnervating target tissues, respectively. Cross-sectional areas
from Block A (normal nerves or proximal host nerve stump) did
not differ between groups. However there were significant
differences between section areas in Block E (normal nerves or
distal host nerve stump) (Fig. 3A–E), the nerve area of NT3 grafts
being significantly larger than the areas of normal nerves, and
acellular and CNTF grafts.
bIII-Tubulin+ axons in cross-sections of proximal (Block A) and
distal (Block E) host nerve stumps and normal PN were counted
and the density of axons/mm2 estimated. There was a significant
interaction between groups and blocks (p,0.0005), meaning that
one variable has an effect on the other; specifically, there was a
significant effect associated with blocks (p,0.005), but no effect
associated with experimental groups. In all grafted nerves there
was a decrease in the average density of bIII-Tubulin+ fibers
between Blocks A and E (Fig. 3F). Moreover, while there were no
significant differences between groups in Block A, in Block E
pairwise comparisons revealed a considerably lower density of
axons in NT3 compared to normal PN.
For each group, the density of bIII-Tubulin+ axons/mm2 in
Block A (proximal stump) was divided by the number in Block E
(distal stump) to obtain a ratio between the two locations. Values
greater than one reflect a higher density of axons proximal versus
distal. As expected, the ratio in normal nerves was close to one.
However, there were disparities in graft groups, and the average
normal nerve ratio differed significantly from the ratios in all graft
groups apart from the unmodified SC group. Moreover, the Block
A/E ratio in NT3 grafts was significantly greater than in acellular,
SC and CNTF groups, consistent with the increased area of the
distal host peroneal stumps in NT3 grafted animals (Fig. 3G).
Figure 2. Survival of Schwann cells in reconstituted peripheral
nerve grafts. (A) Low power view showing GFP and S100 positive
cellular profiles in a section from the middle of a SC-GFP graft. Higher
power views demonstrate: (B) continued GFP transgene expression in
grafted SCs; (C) cells positively immunostained with the SC marker S100;
(D) arrowed GFP and S100 double labelled cells in a combined image.
Scale bars: A = 50 mm; B–D=20 mm.
doi:10.1371/journal.pone.0069987.g002
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Axonal quantification with bIII-Tubulin in longitudinal
sections of grafts
Longitudinal sections from normal PN and Block C (exclusively
graft tissue, Fig. 1) were immunostained with bIII-Tubulin and the
graft width measured at 3 separate locations in each section,
proximal to distal from the CNS (Fig. 4A). Within each group
there was no difference in section width along the length of the
grafts, but section width differed significantly between groups
(Kruskall-Wallis, p,0.0005). BDNF grafts were significantly wider
than normal nerves, and sections of NT3 grafts wider than sections
taken from normal nerves, autograft, acellular, SCs and CNTF
grafts. In each section, the number of immunostained bIII-
Tubulin+ axons/mm (see Fig. 5B,C) was counted at each location
(Fig. 4B). There was no interaction between group and distance,
indicating that these variables were not affecting each other, but
there was an effect of both group (p= 0.020) and distance
(p = 0.018). Namely, there were significantly more bIII-Tubulin+
axons/mm in the autograft compared to CNTF group, and there
were significant differences in the number of bIII-Tubulin+ axons/
mm in proximal versus both middle and distal locations, usually
with fewer axons counted proximally.
A qualitative inspection of sections immunostained for the
macrophage/monocyte marker ED1 revealed very few cells in
normal PN (Fig. 4C), but increased aggregations of ED1 positive
profiles in grafts (Fig. 4D–G), particularly in acellular (Fig. 4D) and
CNTF (Fig. 4F) grafts. Again, compared to normal PN (Fig. 4H),
there was increased expression of laminin in all grafts (Fig. 4I–L),
especially noticeable in acellular grafts (Fig. 4J) and grafts initially
seeded with NT3 expressing SCs (Fig. 4L). The fascicular nature of
laminin immunostaining was a characteristic feature of NT3
grafts.
Axonal regeneration in grafts assessed using PanNF, IB4
and CGRP antibodies
PanNF. Graft sections adjacent to those processed for bIII-
Tubulin were immunostained using a PanNF antibody. In normal
PN, as expected, staining patterns with either antibody appeared
similar (Fig. 5A and 5D). However this was not the case in grafts.
Staining in bIII-Tubulin immunoreacted sections was compara-
tively more homogenous, and long thick axons were intensely
stained (Fig. 5B and 5C), whereas in PanNF immunoreacted
sections the axons were more diffuse and appeared to be more
randomly organized (Fig. 5E and 5F). PanNF+ profiles/mm were
counted at the same location used for bIII-Tubulin quantification
and compared with the number of bIII-Tubulin+ axons/mm using
a linear mixed model including the interaction between group and
axonal marker as a fixed effect. Both group and antibody had
significant effects (respectively, p= 0.015 and p= 0.001). Pairwise
comparisons revealed that the difference in axon counts between
bIII-Tubulin and PanNF antibodies in normal PN differed
significantly from the difference between these antibodies in all
other groups, except autografts. Compared to PanNF there were
significantly more bIII-Tubulin+ axons/mm in acellular, SC and
NT3 grafts (Fig. 5G).
IB4. To further characterize the type of regenerate axons
within grafts, longitudinal sections were immunostained with IB4,
a marker for small, nonpeptidergic, unmyelinated, sensory
nociceptive neurons (Fig. 6A–C). Because this marker is also
reported to label endothelial cells [35–37], only longitudinally
oriented (and clearly not cellular) IB4
+ profiles that were seen in
close association with PanNF+ axons were counted. Counts were
made at similar locations to those selected for the previous bIII-
Tubulin and PanNF counts, revealing significant differences
between groups (p = 0.001). The lowest number of IB4
+ profiles
was seen in autografts (Fig. 6B) and in acellular grafts (not shown).
Subsequent post-hoc comparisons using LSD revealed significantly
more IB4
+ axons in normal PN than in acellular grafts, and more
axons in NT3 grafts than in any other group (Fig. 6C,D).
CGRP. Another series of longitudinal graft sections was
immunostained with a CGRP antibody in order to identify axons
of peptidergic, unmyelinated, nociceptive sensory neurons [23,41].
CGRP+ axons in normal and grafted nerves were counted at the
same location (middle of graft) as other axonal counts. There was
considerable variance and no significant difference between
groups was found, despite a trend to greater numbers of CGRP+
axons in sections of NT3 compared to other groups (Fig. 6E).
Fascicular organization of normal and grafted nerves
Semi-thin cross-sections from the distal end of each graft and
normal PN were collected for assessment of overall tissue
architecture and fascicular morphology. Normal nerves were
mostly homogenous, with many evenly distributed, large myelin-
ated axons and no clear fascicular demarcation (Fig. 7A). On the
other hand, grafted nerves (Fig. 7B–G) consistently contained
discernible fascicles and small axonal bundles. Both autografts
(Fig. 7B) and acellular grafts (Fig. 7C) had the most homogenous
appearance, with compact fascicles. However in grafts containing
unmodified SCs the fascicular organization was slightly more
obvious (Fig. 7D) and in all SC-neurotrophic factor grafts large
fascicles were clearly demarcated. This was obvious in grafts that
had been reconstituted with BDNF (Fig. 7E) and particularly
evident in grafts containing NT3 expressing SCs (Fig. 7G). The
minimum diameter fascicles in unmodified SCs and CNTF grafts
was not significantly different from each other (11.8 and 11.2 mm
respectively); however fascicles in BDNF and NT3 grafts were
significantly larger (Bonferroni, p,0.05, mean diameters of 17.8
and 19.0 mm respectively).
Morphology of Remak bundles
The organization of unmyelinated profiles into Remak bundles
[42–45] in grafted and normal PN was examined in electron
micrographs (Fig. 8). Normal peroneal nerves contained many
large myelinated axons as well as clearly demarcated Remak
bundles containing any number of very tightly grouped unmy-
elinated axons surrounded by a single SC (arrow in Fig. 8A, see
also Table 1). In normal PN, unmyelinated axons in each bundle
were relatively homogenous in size whereas in grafts the variation
was much greater and Remak bundles were less compact (arrow in
Fig. 8B and 8C). The large number of relatively large unmyelin-
Figure 3. bIII-Tubulin+ immunostaining in nerve cross-sections. (A–D) Cross-sections of normal nerve (A) and of distal host nerve stumps of
acellular (B), CNTF (C) and NT3 (D) grafts. (E) Cross-sectional areas of NT3 grafts were significantly larger (*) than areas of normal nerves and of
acellular and CNTF grafts. (F) The density of bIII-Tubulin+ axons/mm2 in all grafted nerves was significantly greater (*) in proximal (Block A) than in
distal (Block E) stumps, and greater (**) in the normal versus NT3 group in Block E. (G) The ratio of bIII-Tubulin+ axons/mm2 between nerve stumps
was significantly lower in normal nerves than in grafts (*), except those with unmodified SCs. The ratio in the NT3 group was significantly greater (**)
than in acellular, SCs and CNTF groups. Values represent M 6 SEM; p,0.0005 in E and G and p,0.05 in F. Further details on statistical analysis
provided as Statistical Information S1. Scale bar for A–D: 100 mm.
doi:10.1371/journal.pone.0069987.g003
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ated axons was noteworthy in BDNF and particularly in NT3
grafts, where some axons were larger than adjacent myelinated
axons (arrows in Fig. 8B and 8D).
Density of unmyelinated axons in Remak bundles
The number of axons in each Remak bundle was quantified
(Table 1). The highest mean was found in the acellular group and
the lowest in the BDNF group. In the latter group there was also
the lowest maximum number of unmyelinated axons in a Remak
Figure 4. Analysis of longitudinal graft sections. (A) Within the grafts themselves (Block C), longitudinal sections of BDNF grafts were
significantly wider (*) than normal nerves, and sections of NT3 grafts were significantly wider (**) than those of normal nerves, autograft, acellular, SCs
and CNTF grafts. (B) Overall, the number of bIII-Tubulin+ axons/mm in longitudinal sections differed between the proximal and other counting
distances (*), with sections of autografts containing significantly more axons (**) compared to CNTF grafts. Values represent M 6 SEM; p,0.025 in A
and p,0.05 in B. Further details on statistical analysis provided as Statistical Information S1. (C–G) ED1 immunostaining; C normal PN; D–G, acellular,
BDNF, CNTF and NT3 grafts respectively. (H–L) laminin immunostaining; F, normal PN; G–L, acellular, BDNF, CNTF and NT3 grafts respectively. Scale for
D–G=200 mm, for C, H–L= 100 mm.
doi:10.1371/journal.pone.0069987.g004
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Figure 5. Representative examples of longitudinal sections of normal nerve (A and D), SCs (B and E) and NT3 (C and F) grafts
immunostained with bIII-Tubulin (A–C) or PanNF (D–F). Images are series of sections from the same nerve or graft. (G) The difference between
bIII-Tubulin+ and PanNF+ axons/mm in the normal group was significantly different from that observed in all groups except the autograft group (*).
The numbers of axons/mm identified by each axonal marker were significantly different (**) in the acellular, SCs and NT3 groups. Values represent M
6 SEM and p,0.05. Further details on statistical analysis provided as Statistical Information S1. Scale bar for A–F: 100 mm.
doi:10.1371/journal.pone.0069987.g005
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bundle, while the highest maximum was in the acellular group,
similar to the number in normal nerves. There were significant
differences between experimental groups (Kruskall-Wallis,
p,0.0005), and a Dunn’s post-hoc test revealed that the median
number of unmyelinated axons in Remak bundles was significantly
greater in acellular and autografts than in SCs, NT3 and BDNF
grafts. The numbers in BDNF were also significantly lower than in
normal PN and CNTF grafts. The frequency of axon numbers in
each bundle was expressed as a percentage of the total number of
counted bundles (Fig. 9). Strikingly, there were almost twice as
many Remak bundles in NT3 grafts (total of 157) than in normal
PN (total of 81) in similar quantified areas. Bundles containing
only a single axon were most common in normal PN and in SC,
BDNF and NT3 grafts.
Myelinated axons
In our pilot sciatic nerve graft study, LV-GFP transduced SCs
with typical adult morphologies were seen wrapping either one or
several regenerate PanNF+ axons at 8 weeks after transplantation
(Fig. 10A). In the main peroneal nerve graft experiment, SC
content was also confirmed in longitudinal sections of normal PN
and in grafts by immunostaining with the marker S100 (Fig. 10B–
D). Myelin content was assessed by co-immunostaining sections
with an MBP antibody. There was clear myelin staining associated
with SC profiles in normal nerves (Fig. 10B) and an even more
conspicuous amount of myelin in sections of autografts (Fig. 10C).
In contrast there was very little stained myelin in NT3 graft
sections (Fig. 10D).
Myelinated axons were counted in semi-thin cross-sections (see
Fig. 7), their density calculated and assessed with a one-way
analysis of variance. Post-hoc comparisons using LSD confirmed
the qualitative immunohistochemical survey in that autografts and
BDNF grafts contained significantly more myelinated axons/mm2
than normal nerves and SC grafts. In addition, autografts,
acellular and BDNF grafts contained more myelinated axons/
mm2 than CNTF and NT3 grafts (Fig. 10E). The density of
unmyelinated axons did not differ between groups (data not
shown), however the ratio of unmyelinated to myelinated axons
did differ significantly (Kruskall Wallis, p = 0.024)(Fig. 10F). In
particular, there was a lower ratio of unmyelinated to myelinated
axons in grafts containing BDNF compared to NT3 expressing
SCs, indicating that these two neurotrophins had opposing
influences on the myelination of regenerated peripheral axons.
Note that the unmyelinated to myelinated axon ratio in our
normal group is similar to the ratio previously reported for normal
cutaneous nerves [43].
G-ratios
The area of individual myelinated axons was larger in normal
PN compared to all graft groups (Table 2). Furthermore, the
average area of myelinated axons in autografts was significantly
greater than in BDNF and NT3 grafts. From the diameter of
myelinated axons and myelinated fibers, the latter including the
myelin sheath, the G-ratio was calculated (dividing the former by
the latter) (Fig. 11). The lower the G-ratio, the greater the
thickness of the myelin sheath around the axon, and generally
speaking, the smaller the axon caliber the lower the G-ratio [46].
Descriptive statistics showed that the highest mean and median G-
ratio was in autografts, followed by acellular, SCs, BDNF and
NT3 grafts, all of which had higher means and medians than
Figure 6. Examples of longitudinal sections of normal (A), autograft (B) and NT3 graft (C) stained with PanNF (red) and IB4 (green).
(D) Quantification revealed significantly greater numbers of IB4
+ axons in normal nerves compared to acellular grafts (*) and in NT3 grafts compared
to all other experimental groups (**). (E) The number of CGRP+ axons was not significantly different between experimental groups. Values represent
M 6 SEM of n = 3; p,0.05. Further details on statistical analysis provided as Statistical Information S1. Scale bar for A–C: 100 mm.
doi:10.1371/journal.pone.0069987.g006
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normal PN. CNTF grafts contained axons with the lowest average
G-ratio amongst all experimental groups (Table 3). G-ratios
differed between groups (Kruskall-Wallis, p,0.0005), and a
Dunn’s post-hoc test revealed that the G-ratio was significantly
lower in normal PN compared to both acellular and autografts. In
the latter, the G-ratio was higher than in any neurotrophic factor
group, and values in the CNTF group were lower than in the SC
group.
Behavioral gait analysis
To assess the impact of neurotrophic factors on functional
recovery, the RatwalkH system was used to analyze gait
parameters in four PN graft groups: SCs, BDNF, CNTF, NT3.
This software was developed for assessing recovery of function
after spinal cord injuries, thus a pilot study was conducted using
animals with sciatic nerve injury to determine which walking
parameters might be the most informative in evaluating recovery
after PN injury. Consistent with a previous study [47], a significant
difference in the mean distance of step length was detected on the
injured side (data not shown), and accordingly it was one of the
parameters selected for analysis in this experiment. Others [48],
reported that the distance between hindlimbs is reduced after
sciatic nerve injury, and there is also abnormal foot rotation [49],
thus stance width was also selected for analysis. In each animal,
stance width and step length were analyzed prior to surgery (PS),
and one (W1) and eight (W8) weeks after PN transplantation
(Fig. 12). Rats were randomly ascribed to different experimental
graft groups before surgery. These normal, PS animals displayed
variation in stance width and step length, such that a comparison
of these parameters between groups failed to reveal significant
differences for either forelimb stance width, or step length on the
left side.
Stance width, the mean distance between the two forelimbs (rf-
lf) or between the two hindlimb (rh-lh), increased significantly from
PS to W1 (p = 0.038) and W8 (p= 0.007) in hindlimbs (rh-lh) of
animals from the CNTF group. In the NT3 group, stance width of
hindlimbs (rh-lh) was significantly greater in W8 than in both W1
(p = 0.034) and PS (p = 0.009).
Step length is the distance between ipsilateral limbs, comprising
the mean distance between right forelimb (rf) and right hindlimb
(rh), or the mean distance between left forelimb (lf) and left
hindlimb (lh). In the NT3 group the step length on the left, grafted
side (lf-lh) increased significantly from PS to W8 (p = 0.01). There
Figure 7. Fascicular architecture in grafts. Semi-thin sections of a
normal nerve (A), an autograft (B), and acellular (C), SCs (D), BDNF (E),
CNTF (F) and NT3 (G) grafts. Note the pronounced fascicular
organization in SC reconstituted grafts, especially in E and G. Scale
bar for A–G: 50 mm.
doi:10.1371/journal.pone.0069987.g007
Figure 8. Unmyelinated axons in Remak bundles. These axons
(black arrows) are shown in representative electron micrographs of
normal nerve (A), BDNF (B), CNTF (C) and NT3 (D) grafts. Scale bar for A–
D: 2.5 mm.
doi:10.1371/journal.pone.0069987.g008
Table 1. Number of axons in each Remak bundle.
Normal Autograft Acellular SC BDNF CNTF NT3
Mean 3.53 3.47 4.52 2.31 1.86 2.81 2.36
SEM 0.397 0.249 0.389 0.192 0.130 0.203 0.161
Variance 12.8 5.5 14.7 3.9 1.5 4.2 4.0
Minimum 1 1 1 1 1 1 1
Maximum 17 11 18 10 7 12 13
1st quartile 1 2 2 1 1 1 1
Median 2 3 3 1 1 2 2
3rd quartile 4.5 4 6 3 2 3 3
Descriptive statistics of the number of unmyelinated axons in Remak bundles,
including mean and standard error of mean (SEM), variance and range of data
distribution represented by minimum and maximum number of axons, and
percentiles distribution, namely first, second (median) and third quartile. There
were significant differences between experimental groups in the median
number of unmyelinated axons in Remak bundles (p,0.0005), with significantly
higher numbers in autografts and acellular grafts than in NT3, SCs and BDNF
grafts. Moreover, the number of unmyelinated axons in the latter was also
significantly lower than in normal nerves and in CNTF grafts. Further details on
statistical analysis provided as Statistical Information S1.
doi:10.1371/journal.pone.0069987.t001
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was a trend associated with the step length on the left side (lf-lh) in
rats from the CNTF group, which almost reached significance
(p = 0.058).
Discussion
Using a new approach combining ex vivo gene therapy of SCs
with transplantation we examined whether neurotrophic factors
delivered via LV-modified SCs in reconstituted PN grafts is a
useful strategy to enhance PN regeneration. In the present series of
experiments we examined the impact of neurotrophic delivery on
graft morphology, axonal regeneration, myelination and function-
al recovery after unilateral peroneal nerve injury. The three factors
chosen (BDNF, CNTF and NT3) have all previously been shown
to be important in various aspects of PN regeneration [50–57].
Using LV-GFP constructs it was found that over 90% of SCs
Figure 9. Occurrence and number of axons in Remak bundles, with pooling of counts between 10–15 and 15–20 axons in bundles.
doi:10.1371/journal.pone.0069987.g009
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continued to express GFP in vitro 48 h after transfection [28], and
here we confirmed in vivo that GFP-expressing SCs colonized the
entire length of grafts and remained viable for at least 8 weeks
post-transplantation. It is important to note that, using some of
these same vectors, previous in vitro and in vivo work has shown
sustained expression of mRNA for growth factor transgenes, and
neurotrophic factors continue to be expressed and secreted by LV-
transduced SCs in vitro and in PN in vivo [22,23,28,29].
Figure 10. Myelination of regenerating axons within grafts. (A) In the pilot sciatic nerve experiment, cross-sections from the middle of GFP-SC
grafts showed profiles with typical SC morphology (green) surrounding axons labelled with PanNF (red). (B–D) In the main peroneal graft experiment,
comparison of longitudinal sections immunostained with S100 (green) and MBP (red) showed that normal nerves (B) had less myelin than autografts
(C) and more myelin than NT3 grafts (D). (E) Quantification of semi-thin sections revealed that the number of myelinated axons/mm2 in normal nerves
and SCs grafts was significantly lower (*) than in autografts and BDNF grafts, and the numbers in the latter two and in acellular grafts were
significantly greater (**) than in CNTF and NT3 grafts. (F) The ratio of unmyelinated to myelinated axons in the BDNF group was significantly less than
in the NT3 group. Values represent M 6 SEM of n = 3; p,0.05. Further details on statistical analysis provided as Statistical Information S1. Scale bars:
10 mm in A; 100 mm for B–D.
doi:10.1371/journal.pone.0069987.g010
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Figure 11. G-ratios of myelinated fibers in each experimental group (120 fibers measured in each group). Note the greater number of
large diameter axons in normal nerve and in autografts, the G-ratio in the latter being the highest of all experimental groups and significantly higher
than in the normal, BDNF, CNTF and NT3 groups. The G-ratio values were also significantly lower in normal nerves compared to acellular grafts and
significantly higher in SC compared to CNTF grafts (see also Table 3). Further details on statistical analysis provided as Statistical Information S1.
doi:10.1371/journal.pone.0069987.g011
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Most graft types supported axonal regrowth at similar densities,
although CNTF grafts possessed the fewest axons. NT3 grafts were
notable in containing a high density of IB4 and CGRP labelled
sensory axons when compared to other graft types, including
autografts. In terms of morphology, fascicles of axons were
especially evident in grafts containing SCs expressing BDNF or
NT3. The proportion of myelinated axons was highest in BDNF
grafts and lowest in NT3 grafts. Consistent with the morphological
data, functional analysis of stance width and step length revealed
changes in the locomotor performance of rats in the CNTF and
especially NT3 groups. Such changes were associated with the
operated left hindlimb and were not observed in the control SC
group. An overview of the effects of the tested neurotrophic factors
on each of the assessed regenerative parameters is presented in the
summary Table (Table 4) and will be further discussed below.
Regeneration in PN grafts containing LV-modified
Schwann cells
Host nerve stumps distal to NT3 grafts were the widest and the
density of bIII-Tubulin+ axons/mm2 was lowest in this group.
Factors that may have influenced the cross-sectional area of distal
host nerve stumps include axonal number, extent of myelination,
immune and glial cell infiltration and/or proliferation, and
amount of extracellular matrix. Within most grafts there were
significantly less axons counted proximally versus distally, perhaps
due to local sprouting and/or axons becoming entangled within
grafts as they approached the distal suture area. NT3 grafts
themselves were wider than normal peroneal nerve and other graft
types, in accordance with reported effects of this neurotrophin on
increased proliferation [58], migration [59] and survival [60] of
SCs in grafts. Injury-induced NT3 levels increase in the sciatic
nerve up to a month after ventral root avulsion and reimplantation
[61], thus expression of NT3 by SCs within reconstituted grafts
may have enhanced local axonal sprouting, known to occur during
regeneration [3,57]. NT3 grafts also possessed high laminin
immunoreactivity and at EM level showed signs of increased
extracellular matrix deposition, especially evident between, and
surrounding, the large fascicular bundles (eg Fig. 7G). In counts
from longitudinal sections, CNTF grafts contained the least
number of axons, a surprising outcome given that this neuro-
trophic factor is thought to play an important role after PN injury
[62,63]. Interestingly, these grafts contained a large number of
ED1 positive macrophages/monocytes, consistent with previous
reports that CNTF is a chemotactic agent for these cells [64,65].
In some graft groups there were intriguing differences in axonal
counts in near adjacent longitudinal sections immunostained for
either bIII-Tubulin or PanNF. Counts of PanNF and bIII-Tubulin
stained profiles/mm were similar in normal nerves, however there
were consistently fewer PanNF+ fibers within grafts. The
neurofilament proteins identified by PanNF are related to axonal
caliber, with increases in axonal diameter generally correlating
with increased neurofilament content [66]. This makes PanNF a
marker particularly suitable for identifying axons of large caliber.
After axotomy the slow transport of neurofilaments along axons is
associated with a smaller caliber of regenerated axons, which could
explain the reduction in the number of PanNF+ profiles in all
grafts. bIII-Tubulin expression selectively increases during axonal
regrowth and is added near the tip of regenerating axons [67–70],
thus making bIII-Tubulin a more general marker for regenerating
axons, irrespective of their caliber. It is therefore of interest that
axonal counts using bIII-Tubulin immmunohistochemistry were
significantly greater in acellular, untransduced SC and NT3 grafts,
perhaps indicative of a greater proportion of small caliber
regenerating sprouts in these particular grafts.
IB4 and CGRP counts
The number of axons positive for IB4 was greatest in NT3
grafts. IB4
+ sensory neurons are small nonpeptidergic nociceptors
with unmyelinated axons, responsive to glial cell-derived neuro-
trophic factor (GDNF) but not nerve growth factor (NGF) [71],
and express tyrosine kinase RET and subunits of the GDNF
receptor family [72]. They have been reported to be vulnerable to
injury and have poor regenerative capacity [34,73]. In adults,
NT3 and GDNF rescue specific subpopulations of DRG neurons
[74,75], but to our knowledge IB4
+ neurons do not express trkC
receptors [76]. In vitro, NT3 has little effect on neurite expression
from cultured IB4
+ adult sensory neurons and may even have
growth-inhibitory effects [76]. Further work is needed to
determine if the observed effects of NT3 in our in vivo model are
indirect, perhaps acting via host cells that colonize the grafts.
CGRP is found in peptidergic, unmyelinated, nociceptive,
sensory neurons, expressing substance P [23,41], and has also
been reported to be present in motor neurons [77]. DRG
neurons expressing CGRP are responsive to CNTF, GDNF and
NGF, and express trkA and p75 receptors [72], and the peptide
is up-regulated after PN injury [78]. The highest numbers of
CGRP+ axons was found in NT3 grafts and the lowest in BDNF
grafts. Again, the mechanisms underlying these effects are
Table 2. Area of individual myelinated axons.
Normal Autograft Acellular SC BDNF CNTF NT3
Mean 9.5 3.6 2.1 2.0 1.9 1.9 1.6
SEM 0.633 0.406 0.209 0.175 0.233 0.202 0.163
Variance 48.1 19.8 5.2 3.7 6.5 4.9 3.2
Minimum 0.65 0.14 0.19 0.16 0.16 0.14 0.20
Maximum 33.00 25.90 12.90 12.20 18.80 13.70 10.96
1st quartile 4.15 0.78 0.68 0.76 0.63 0.67 0.49
Median 8.12 1.94 1.30 1.36 1.18 1.31 1.03
3rd quartile 13.15 4.66 2.67 2.51 2.18 2.46 2.00
Descriptive statistics of areas of myelinated axons, including mean and standard
error of mean (SEM), variance and range of the distribution represented by
minimum and maximum, and percentile distribution, namely first, second
(median) and third quartile.
doi:10.1371/journal.pone.0069987.t002
Table 3. G ratios.
Normal Autograft Acellular SC BDNF CNTF NT3
Mean 0.44 0.52 0.49 0.48 0.46 0.43 0.46
SEM 0.007 0.011 0.01 0.01 0.012 0.01 0.01
Variance 0.006 0.014 0.013 0.012 0.017 0.011 0.013
Minimum 0.268 0.20 0.191 0.214 0.20 0.18 0.25
Maximum 0.681 0.75 0.689 0.757 0.73 0.66 0.80
1st quartile 0.40 0.44 0.40 0.40 0.37 0.36 0.38
Median 0.45 0.52 0.50 0.46 0.45 0.42 0.45
3rd quartile 0.50 0.60 0.58 0.56 0.57 0.50 0.55
Descriptive statistics of G-ratios in each group including mean and standard
error of mean (SEM), variance and range of the distribution with minimum and
maximum values, as well as percentile distribution, including first, second
(median) and third quartile. Further details on statistical analysis provided as
Statistical Information S1.
doi:10.1371/journal.pone.0069987.t003
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unclear, although in vitro, BDNF has been reported to inhibit
neurite outgrowth from cultured adult sensory neuron popula-
tions [76].
Fascicular architecture and Remak bundles
Interestingly, unlike normal PN, a clear fascicular organization
was evident in grafts, particularly those containing SCs expressing
Figure 12. Locomotor function of rats from SC, BDNF, CNTF and NT3 groups prior to surgery (PS), and at one (W1) and eight (W8)
weeks after surgery, was analyzed from digitized recordings using the RatwalkH software. Two quantitative parameters generated by
this software were analyzed: stance width (A–D) and step length (E–H). There were significant differences in both parameters in distances involving
the injured left hindlimbs. Namely, the stance width of hindlimbs (rh-lh) in the CNTF group significantly increased from PS (* in C) to W1 and W8, and
in the NT3 group it was significantly greater in W8 (* in D) than in both W1 and PS. Regarding the step length on the left (lf-lh), in the NT3 group there
was a significant increase (* in H) from PS to W8. There were no significant differences in either the SC or BDNF groups on the two gait parameters
analyzed. Values represent M 6 SEM of n = 4; p,0.05.
doi:10.1371/journal.pone.0069987.g012
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BDNF or NT3. Demarcation of fascicles appeared to result from
intra- and inter-fascicular deposition of collagen and from loosely
organized Remak bundles. All graft types were more heteroge-
neous in structure than normal PN, perhaps due to greater
amounts of extracellular matrix, but also the relative absence of
myelin may allow for greater plasticity within regenerated nerves
[44].
In normal PN, unmyelinated axons were closely wrapped by a
Remak SC, but in grafts the bundles were less compact and
contained variable numbers of unmyelinated profiles, the highest
average number in acellular grafts and the lowest in BDNF grafts.
However in the latter and in NT3 grafts there were numerous
relatively large unmyelinated axons, suggesting that besides axon
caliber [79] these factors play an important role in regulating
myelination during regeneration. Axonal areas were comparative-
ly small in BDNF grafts, nonetheless most axons were myelinated.
Indeed, BDNF grafts contained a greater density of myelinated
axons compared to normal PN and they contained the lowest
median ratio between unmyelinated and myelinated axons,
consistent with an enhanced myelination profile after BDNF
delivery [53,55,80]. Mice lacking BDNF possess fewer myelinated
axons [81], and BDNF antibodies reduce the number and density
of myelinated fibers after sciatic nerve injury [52].
Myelination
NT3 grafts contained an average unmyelinated to myelinated
axon ratio of 8:1. Unmyelinated axon numbers per bundle were
relatively low, however the overall density of Remak bundles was
greatest in these grafts. The presence of large diameter but
unmyelinated axons in each Remak bundle, together with the
smaller proportion of myelinated axons, supports the view that
NT3 inhibits SC myelination [82,83]. Grafts containing CNTF
expressing SCs also had low myelinated axon densities, however
the mean area of myelin per axon was greater in the CNTF group
compared to axons in BDNF grafts, indicating different effects on
myelination from each of these factors. G-ratios in BDNF grafts
were greater than in normal PN, suggesting that BDNF enhanced
myelination by increasing the number of axons that were
myelinated, not necessarily by increasing the amount of myelin
around a given axon. On the other hand, myelinated axons in
CNTF grafts had a relatively small average G-ratio. Given that
axonal areas were significant smaller in CNTF grafts compared to
normal PN, these data indicate that the relative thickness of myelin
around each axon had increased, consistent with a role for CNTF
in PNS myelination [55,84].
Functional analysis
We tested overall locomotor function after grafts to the mixed
peroneal nerve because, after PN injuries in rodents, assessment of
functional recovery is difficult, particularly when measuring
discrete and specific somatosensory properties, due to the need
for repetitive and accurate stimulation of the same skin region,
overlapping innervation fields [85] and because the fields change
after nerve injury [86]. Walking patterns were analyzed using the
RatwalkH system, which is similar to the Catwalk system and
allows the objective and quantitative assessment of dynamic and
static gait parameters [30,87–89]. Stance width was wider between
hindlimbs than between forelimbs, even before the injury.
However in the group with CNTF grafts hindlimb stance width
was increased at 1 and 8 weeks after injury, and in the NT3 group
the distance between hindlimbs was significantly increased at 8
weeks. At the latter time the step length between left forelimb and
injured left hindlimb was also greater in the NT3 group. Others
have reported increased step length on the injured side after
peroneal nerve crush [47], although in the earlier study step length
distance returned to normal after 22 days, whereas here an altered
gait was still a feature of NT3 grafted rats 8 weeks post-injury,
probably due to differences in the type of injury.
Table 4. Summary of data.
BDNF CNTF NT3




Widest of all and significantly
wider than others
Fascicles Clearly apparent Apparent Clearly apparent
Remak bundles Fewer than in other NTF grafts Highest number
Axonal regeneration bIII-Tubulin Fewer than in all
other grafts
Lowest number of axons/
mm2
PanNF Low number
IB4 Low number Highest number
CGRP Low number Highest number
Myelination Unmyelinated axons Lowest number and lower
than normal nerves
Myelinated axons More than in normal nerves
or other NTF grafts
Low density but with
high mean area of myelin
Fewer than in normal nerves
and any other grafts






G-ratio High Lowest of all groups High
Functional recovery Stance width of hindlimbs Significantly increased
from PS to W1 and W8
Significantly greater at W8
than PS and W1
Step length on the left Significant increase from PS
to W8
General overview of tested neurotrophic factors (NTF), which were BDNF, CNTF and NT3, on the various regenerative parameters examined, namely, grafts morphology,
axonal regeneration, myelination and functional recovery. The latter included three time-points: pre-surgery (PS), one week (W1) and eight weeks (W8) after surgery.
doi:10.1371/journal.pone.0069987.t004
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NGF and associated receptors are generally thought to be
important in neuropathic pain responses after PN injury [90,91],
although recent work has suggested that NT3 may also play a role
in hypersensitivity and pain, associated with the sprouting of
sensory nerves after skin injury [92]. There was a significant
increase in the number of (nociceptive) IB4+ axons in our NT3
grafts and we noted in these rats that the paw-prints from the
injured left hindlimb were often light and barely distinguishable,
suggestive of decreased pressure in the left hindlimb. After repair
of peroneal defects, autotomy was only infrequently observed and
did not vary between graft groups, suggesting no severe changes in
sensory responsiveness; nonetheless any altered mechanosensitivity
in the injured left hindlimb could have contributed to the changes
in stance and step length seen during locomotion.
In conclusion, our novel method of using LV-engineered SCs in
chimeric bridging grafts to deliver targeted neurotrophic support
to regenerating axons after PN injury has revealed that each factor
has a spectrum of effects on the overall regenerative process. There
were differences in graft morphology, extent of myelination and
type of axon regenerating through the grafts. Functional
differences were also apparent. Given that SC phenotype differs
in motor versus sensory nerves [4], and different axonal
populations have different neurotrophic requirements, this new
approach using genetically modified SCs in reconstituted bridges
may permit more selective and effective stimulation of sub-
populations of motor or sensory neurons after defined injury to a
particular PN or branch of the nerve.
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